Clinical Study Of Migraine Evolution

GlaxoSmithKline250 enrolled

Overview

Understanding the speed at which migraine headaches develop is of importance to patients. Determining the proportions in which different headache pain build-up occurs, may provide health care practitioners with valuable information with which to prescribe the most appropriate treatment. Patients who experience a slow pain build-up may gain more benefit from medications which have a slow onset of effect, high tolerability and long action. Conversely, medications with a rapid onset of effect may be of greater benefit to patients who experience rapid onset of migraine pain.

Study Type

OBSERVATIONAL

Enrollment

250

Conditions

Migraine Headache

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subject is outpatient. * Subject has a diagnosis of migraine with/without aura according to IHS criteria, of at least 1 years duration. * Subject is able to comprehend the study procedures and to comply with study requirements. Exclusion Criteria: * Subject has other chronic pain condition(s) not associated with migraine * Subject is unable to understand the schedule/questionnaire.

Locations (10)

GSK Clinical Trials Call Centre

Calgary, Alberta, Canada

GSK Clinical Trials Call Centre

Richmond, British Columbia, Canada

GSK Clinical Trials Call Centre

Vancouver, British Columbia, Canada

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.